Copyright
©The Author(s) 2023.
World J Hepatol. Mar 27, 2023; 15(3): 410-418
Published online Mar 27, 2023. doi: 10.4254/wjh.v15.i3.410
Published online Mar 27, 2023. doi: 10.4254/wjh.v15.i3.410
Table 1 Baseline patient characteristics, n (%)
| Baseline patient characteristic | Met screening criteria (n = 463) | Failed screening criteria (n = 545) | P value |
| Age | 61.4 ± 10.7 | 60.2 ± 10.5 | 0.06 |
| Gender | 0.37 | ||
| Male | 261 (56) | 292 (54) | |
| Female | 202 (44) | 253 (46) | |
| Race | 0.85 | ||
| White | 385 (83) | 452 (83) | |
| African-American | 48 (10) | 55 (10) | |
| Other | 20 (4) | 30 (6) | |
| Unknown | 5 (1) | 5 (1) | |
| County of residence | 0.61 | ||
| Same county as institution | 115 (25) | 143 (26) | |
| Different county than institution | 348 (75) | 402 (74) | |
| Etiology | 0.64 | ||
| NASH | 144 (31) | 157 (29) | |
| AIH | 21 (5) | 25 (5) | |
| PBC | 34 (7) | 37 (7) | |
| PSC | 19 (4) | 13 (2) | |
| HCV | 229 (49) | 283 (52) | |
| HBV | 29 (6) | 37 (7) | |
| AALD | 44 (10) | 63 (12) | |
| MELD | 8.2 ± 3.8 | 8.1 ± 3.8 | 0.65 |
- Citation: King WW, Richhart R, Culpepper T, Mota M, Banerjee D, Ismael M, Chakraborty J, Ladna M, Khan W, Ruiz N, Wilson J, Altshuler E, Clark V, Cabrera R. Adherence to guideline-directed hepatocellular carcinoma screening: A single-center US experience. World J Hepatol 2023; 15(3): 410-418
- URL: https://www.wjgnet.com/1948-5182/full/v15/i3/410.htm
- DOI: https://dx.doi.org/10.4254/wjh.v15.i3.410